ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Program Project Guidelines Listed

March 18, 1977

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012

Symposium Planned On Hyperthermia

April 23, 1976